Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07416734 · ClinicalTrials.gov registry record · NA
RCT of HeartBot in Women
A NA study, sponsored by University of California, San Francisco.
- Not yet
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT07416734 is a NA study that has not yet begun recruiting, run by University of California, San Francisco. The registered enrollment target is 200 participants.
The verdict
NCT07416734, a NA study, has not yet begun recruiting, sponsored by University of California, San Francisco.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to find out whether an app-based program called HeartBot II, which uses an artificial intelligence (AI) chatbot, can help improve women's awareness and knowledge of heart attacks in women. This is an online study with about 200 women taking part. Participants will be randomly assigned (by chance) to one of two groups: an intervention group or a wait-list control group. Participants in the intervention group will begin using the HeartBot II program right away. Participants in the wait-list control group will wait 12 weeks before starting the HeartBot II program. The HeartBot II program includes four short modules. In each module, participants will interact with a chatbot and spend about 10 to 15 minutes completing the content. Participants will be asked to complete an online screening and baseline survey at the start of the study, as well as two follow-up surveys at 12 weeks and 24 weeks.
Interventions
- OTHER Waitlist Control
- OTHER HeartBot II Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2026-03-01 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07416734
The ClinicalTrials.gov registry entry for NCT07416734 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Waitlist Control is the first listed.
NCT07416734 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07416734 about?
NCT07416734 is a clinical study titled "RCT of HeartBot in Women". The goal of this clinical trial is to find out whether an app-based program called HeartBot II, which uses an artificial intelligence (AI) chatbot, can help improve women's awareness and knowledge of heart attacks in women. This is an online study with about 200 women taking part. Participants will...
What is the current status of trial NCT07416734?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2026-03-01. Estimated completion is 2027-06-30.
What interventions are being tested in trial NCT07416734?
The interventions under investigation include: Waitlist Control (OTHER), HeartBot II Program (OTHER).
Who is sponsoring clinical trial NCT07416734?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.